China Universal Asset Management Company’s scPharmaceuticals SCPH Stock Holding History

China Universal Asset Management Company’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,342	Closed	-$53K	–	527
2025 Q3	$53K	Sell	9,342 -1,261	-12%	-$6.46K	﹤0.01%	427
2025 Q2	$40.4K	Buy	10,603 +566	+6%	+$1.76K	﹤0.01%	431
2025 Q1	$26.4K	Sell	10,037 -573	-5%	-$1.87K	﹤0.01%	450
2024 Q4	$37.6K	Buy	+10,610	New	+$40.6K	﹤0.01%	466

China Universal Asset Management Company's SCPH Position: Q4 2025 in Review

China Universal Asset Management Company sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 9,342 shares — an estimated $53K sold.

China Universal Asset Management Company first reported a position in SCPH in Q4 2024 and held it in 4 quarters. The position peaked at $53K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

China Universal Asset Management Company reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
China Universal Asset Management Company sold 9,342 scPharmaceuticals shares in Q4 2025, an estimated $53K.
China Universal Asset Management Company first reported a position in scPharmaceuticals in Q4 2024 and held it in 4 quarters.
China Universal Asset Management Company's scPharmaceuticals position peaked at $53K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.